Endothelial dysfunction, arterial stiffening, and intima-media thickening in large arteries from HIV-1 transgenic mice.
Endothelial dysfunction, arterial stiffening, and intima-media thickening in large arteries from HIV-1 transgenic mice.
复制标题
DOI:
10.1007/s10439-012-0702-5
复制
发表时间:
2013-04
影响因子:
3.8
通讯作者:
Gleason, Rudolph L., Jr.
中科院分区:
文献类型:
--
作者:
Hansen, Laura;Parker, Ivana;Sutliff, Roy L.;Platt, Manu O.;Gleason, Rudolph L., Jr.
HIV patients on highly active antiretroviral therapy (HAART) exhibit elevated incidence of cardiovascular disease, including a higher risk of myocardial infarction and prevalence of atherosclerotic lesions, as well as increases in markers of subclinical atherosclerosis including increased carotid artery intima-media thickness, increased arterial stiffness, and impaired flow-mediated dilation. Both HAART and HIV-infection are independent risk factors for atherosclerosis and myocardial infarction. Studies implicate the HIV proteins tat, gp120, vpu, and nef in early on-set atherosclerosis. The objective of this study was to quantify the role of expression of HIV-1 proteins on the vascular function, biomechanics, and geometry of common carotid arteries and aortas. This study employed NL4-3Δ gag/pol transgenic mice (HIV-Tg), which contain the genetic sequence for the HIV-1 proteins env, tat, nef, rev, vif, vpr, and vpu but lacks the gag and pol genes and reports that HIV-Tg mice have impaired aortic endothelial function, increased carotid intima-media thickness (c-IMT), and increased arterial stiffness. Further, HIV-Tg arteries show decreased elastin content, increased cathepsin K and cathepsin S activity, and increased mechanical residual stress. Thus, mice that express HIV proteins exhibit pre-clinical markers of atherosclerosis and these markers correlate with changes in markers of vascular remodeling. These findings are consistent with the hypothesis that HIV-proteins, independent of HAART treatment or HIV infection, could play a role in of the development of cardiovascular disease.
登录
查看更多内容
影响因子:
3.8
作者:
Mary-Krause, M;Cotteb, L;Costagliola, D
通讯作者:
Costagliola, D
影响因子:
37.8
作者:
Lutgens, E;Lutgens, SPM;Cleutjens, KBJM
通讯作者:
Cleutjens, KBJM
影响因子:
6.4
作者:
Grubb, JR;Dejam, A;Gladwin, MT
通讯作者:
Gladwin, MT
影响因子:
37.8
作者:
Hsue, PY;Lo, JC;Waters, DD
通讯作者:
Waters, DD
DOI:
10.1097/qad.0b013e32830fe35e
发表时间:
2008-09-12
期刊:
AIDS (London, England)
影响因子:
--
作者:
Strategies for Management of Anti-Retroviral Therapy/INSIGHT;DAD Study Groups
通讯作者:
DAD Study Groups